PET Imaging of Tau Pathology in Alzheimer's Disease and Tauopathies.
about
Drug Development in Alzheimer's Disease: The Contribution of PET and SPECTPET Imaging of Epigenetic Influences on Alzheimer's DiseaseOcular indicators of Alzheimer's: exploring disease in the retinaAlzheimer Disease and Its Growing Epidemic: Risk Factors, Biomarkers, and the Urgent Need for Therapeutics.Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease.Meta-Analysis of Transcriptome Data Related to Hippocampus Biopsies and iPSC-Derived Neuronal Cells from Alzheimer's Disease Patients Reveals an Association with FOXA1 and FOXA2 Gene Regulatory Networks.[Molecular imaging in neurological diseases].Antibody-free quantification of seven tau peptides in human CSF using targeted mass spectrometry.Multimodality Review of Amyloid-related Diseases of the Central Nervous System.Aberrant brain stem morphometry associated with sleep disturbance in drug-naïve subjects with Alzheimer's diseasePharmacokinetic Evaluation of the Tau PET Radiotracer 18F-T807 (18F-AV-1451) in Human Subjects.Amyloid-beta immunotherapy: the hope for Alzheimer disease?PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid BiomarkersA Theoretical Analysis of the Synergy of Amyloid and Tau in Alzheimer's Disease.Neurologic Applications of PET/MR Imaging.Emerging ocular biomarkers of Alzheimer disease.Inhomogeneous distribution of Alzheimer pathology along the isocortical relief. Are cortical convolutions an Achilles heel of evolution?Tau imaging with [18 F]THK-5351 in progressive supranuclear palsy.Alzheimer's disease disrupts alpha and beta-band resting-state oscillatory network connectivity.Comparative analysis of the electroencephalogram in patients with Alzheimer's disease, diffuse axonal injury patients and healthy controls using LORETA analysis.Tauopathies: Mechanisms and Therapeutic Strategies.A Quantitative Analysis of Brain Soluble Tau and the Tau Secretion Factor.Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies.Current Perspectives regarding Stem Cell-Based Therapy for Alzheimer's Disease.Potential Utility of Retinal Imaging for Alzheimer’s Disease: A Review.A Closer Look into the Role of Protein Tau in the Identification of Promising Therapeutic Targets for Alzheimer's DiseaseF-labeled radiopharmaceuticals for the molecular neuroimaging of amyloid plaques in Alzheimer's disease
P2860
Q26749755-B232FFE4-5DB8-4384-8DA9-28CE92260CD1Q26776178-E4FFD8E8-51CE-4FD8-A0DD-A5B5B1A37CFFQ28078670-DDE6D142-325F-4BF6-97B7-0BBCF022F248Q30244736-FF420F77-3491-4393-8A8A-5B42BC83F96BQ30276980-60CF70C8-2B57-4358-88C5-41CA6EB763F0Q31047629-0E149F07-2008-4A72-939E-2DDBC4E76FD1Q31108303-14C4D1DF-CCFA-4214-89F4-D9DE47868EAFQ36012068-A6783344-DFE5-482B-8B22-7FA2609DFF32Q37157690-70491E6E-54C5-4331-9C7C-C9832C754139Q37213267-8BC476F4-7CF6-4A86-8AD5-D7B66105AC32Q37677783-76079562-1625-45DB-961E-A285319A1F17Q37679265-8A7C1329-1FBE-478E-BAB0-2042A8890D32Q38628805-BF4FFC3D-260E-4ACE-A1B4-42F4A01954FCQ38814839-70878D51-A168-4BCB-8839-E998ED505511Q38846608-B79A9B36-AE1D-4A4F-8894-81B96673F643Q39113804-6550EF56-3F1C-4C71-80F7-28E38361A0F0Q39165848-A06A197C-33B1-4605-A759-18F25C351027Q42501180-C45C449E-87EB-4BCA-9D98-E9694F878A32Q46323013-92F69C00-1694-41DD-A3DB-2BB6D94F6E38Q47100093-37A8DB6A-6E26-4616-B05E-EA76E26C0A5BQ47253592-F78C75CB-6232-4ED6-A483-52DD94034981Q47833026-1268C380-FD64-43D4-B0BA-629DD8D3D1BAQ48389127-A2926183-DFF7-4AFA-9657-AA33BB86B049Q52568314-FF30A96F-BD18-4C03-AB47-0330D3B0B346Q55480248-727376B6-A982-4CC4-94A1-1A7544E7EB20Q57927766-602A080B-A990-4688-B7CC-E4B4DEEE017BQ58733228-8A3A1B7F-B1E0-4306-B746-B0843EAF05B2
P2860
PET Imaging of Tau Pathology in Alzheimer's Disease and Tauopathies.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
PET Imaging of Tau Pathology in Alzheimer's Disease and Tauopathies.
@ast
PET Imaging of Tau Pathology in Alzheimer's Disease and Tauopathies.
@en
type
label
PET Imaging of Tau Pathology in Alzheimer's Disease and Tauopathies.
@ast
PET Imaging of Tau Pathology in Alzheimer's Disease and Tauopathies.
@en
prefLabel
PET Imaging of Tau Pathology in Alzheimer's Disease and Tauopathies.
@ast
PET Imaging of Tau Pathology in Alzheimer's Disease and Tauopathies.
@en
P2093
P2860
P356
P1476
PET Imaging of Tau Pathology in Alzheimer's Disease and Tauopathies.
@en
P2093
Olga G James
P Murali Doraiswamy
Salvador Borges-Neto
P2860
P356
10.3389/FNEUR.2015.00038
P577
2015-03-09T00:00:00Z